New regulations for surveillance of medical devices come into force
On 16 June 2025, new Post-Market Surveillance (PMS) regulations came into force. As part of the Medicines and Healthcare products Regulatory Agency’s (MHRA) efforts to transform the UK's medical devices regulatory framework, the new PMS regulations will require manufacturers of medical devices to be involved in safety and performance checks of products already on the market. The regulations apply to all devices that are placed on the market in Great Britain after 16 June 2025 and are UKCA- and CE-marked. Manufacturers will need to implement surveillance systems that enable monitoring of devices in use, collection of safety data and reporting of incidents.
GDC publishes annual report and accounts for 2024
The General Dental Council’s (GDC) Annual Report and Accounts 2024 highlights record registration figures, with 12,978 applications processed and 11,892 new dental professionals joining the register. The report details significant improvements to fitness to practise processes, including halving the average assessment time for single-patient concerns and clearing the previous year’s backlog. Sector leadership was demonstrated through Dental Leadership Network events and extensive stakeholder engagement, addressing challenges facing patients and professionals. Notable developments include enhanced workforce data collection, increased capacity for Overseas Registration Examinations, and priority booking for refugees. The GDC updated its values and Equality, Diversity and Inclusion strategy, met 16 of 18 regulatory standards, and launched consultations on new guidance and its Corporate Strategy for 2026–2028.
Cosmetic procedures – regulations in sight to protect the public
The Department of Health and Social Care has recently announced plans to tighten rules on high-risk cosmetic procedures. The strict new measures are be designed to crack down on what are often referred to as 'cowboy cosmetic procedures' that have left patients with dangerous complications and in need of urgent medical treatment. This follows a number of high-profile injuries, and the first UK death, after non-surgical 'botched' Brazilian butt lift procedures. Medical professionals have long called for regulatory intervention, urging the government to restrict performance of these services to trained medical professionals in an appropriate environment. Through its Plan for Change, the Department of Health and Social Care will publish a consultation early next year, formalising its strategies to improve the safety of the highest-risk procedures. In addition to the regulations for non-surgical procedures deemed the highest risk, such as the Brazilian butt lift, this will include new restrictions for under 18s and a new local authority licensing system for lower-risk cosmetic treatments, including Botox and facial dermal fillers. These new measures should also benefit the NHS, alleviating the pressure on urgent treatment for injuries sustained in these high-risk procedures.
